RT22_HUMAN - dbPTM
RT22_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RT22_HUMAN
UniProt AC P82650
Protein Name 28S ribosomal protein S22, mitochondrial
Gene Name MRPS22
Organism Homo sapiens (Human).
Sequence Length 360
Subcellular Localization Mitochondrion .
Protein Description
Protein Sequence MAPLGTTVLLWSLLRSSPGVERVCFRARIQPWHGGLLQPLPCSFEMGLPRRRFSSEAAESGSPETKKPTFMDEEVQSILTKMTGLNLQKTFKPAIQELKPPTYKLMTQAQLEEATRQAVEAAKVRLKMPPVLEERVPINDVLAEDKILEGTETTKYVFTDISYSIPHRERFIVVREPSGTLRKASWEERDRMIQVYFPKEGRKILTPIIFKEENLRTMYSQDRHVDVLNLCFAQFEPDSTEYIKVHHKTYEDIDKRGKYDLLRSTRYFGGMVWYFVNNKKIDGLLIDQIQRDLIDDATNLVQLYHVLHPDGQSAQGAKDQAAEGINLIKVFAKTEAQKGAYIELTLQTYQEALSRHSAAS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
24UbiquitinationSPGVERVCFRARIQP
CCCCCEEEEEEECCC
2.0923503661
25UbiquitinationPGVERVCFRARIQPW
CCCCEEEEEEECCCC
6.6523503661
26UbiquitinationGVERVCFRARIQPWH
CCCEEEEEEECCCCC
20.1623503661
43PhosphorylationLLQPLPCSFEMGLPR
CCCCCCCCCCCCCCC
23.4624719451
54PhosphorylationGLPRRRFSSEAAESG
CCCCCCCCHHHHHCC
26.0026471730
55PhosphorylationLPRRRFSSEAAESGS
CCCCCCCHHHHHCCC
28.6626471730
57UbiquitinationRRRFSSEAAESGSPE
CCCCCHHHHHCCCCC
20.6222817900
58UbiquitinationRRFSSEAAESGSPET
CCCCHHHHHCCCCCC
13.8722817900
62PhosphorylationSEAAESGSPETKKPT
HHHHHCCCCCCCCCC
28.9221815630
62UbiquitinationSEAAESGSPETKKPT
HHHHHCCCCCCCCCC
28.9221890473
63UbiquitinationEAAESGSPETKKPTF
HHHHCCCCCCCCCCC
57.7221890473
65UbiquitinationAESGSPETKKPTFMD
HHCCCCCCCCCCCCH
47.9923503661
66UbiquitinationESGSPETKKPTFMDE
HCCCCCCCCCCCCHH
55.9123503661
67UbiquitinationSGSPETKKPTFMDEE
CCCCCCCCCCCCHHH
57.6223503661
69PhosphorylationSPETKKPTFMDEEVQ
CCCCCCCCCCHHHHH
40.2330619164
71SulfoxidationETKKPTFMDEEVQSI
CCCCCCCCHHHHHHH
7.5421406390
77PhosphorylationFMDEEVQSILTKMTG
CCHHHHHHHHHHHHC
25.4124719451
81UbiquitinationEVQSILTKMTGLNLQ
HHHHHHHHHHCCCCH
30.9022817900
82UbiquitinationVQSILTKMTGLNLQK
HHHHHHHHHCCCCHH
2.7922817900
85UbiquitinationILTKMTGLNLQKTFK
HHHHHHCCCCHHHCH
4.2022817900
86UbiquitinationLTKMTGLNLQKTFKP
HHHHHCCCCHHHCHH
41.5922817900
92UbiquitinationLNLQKTFKPAIQELK
CCCHHHCHHHHHHHC
38.4829967540
98UbiquitinationFKPAIQELKPPTYKL
CHHHHHHHCCCCHHH
6.0622817900
99UbiquitinationKPAIQELKPPTYKLM
HHHHHHHCCCCHHHC
48.4722817900
103UbiquitinationQELKPPTYKLMTQAQ
HHHCCCCHHHCCHHH
14.1121890473
103UbiquitinationQELKPPTYKLMTQAQ
HHHCCCCHHHCCHHH
14.1121890473
104UbiquitinationELKPPTYKLMTQAQL
HHCCCCHHHCCHHHH
33.9722817900
105UbiquitinationLKPPTYKLMTQAQLE
HCCCCHHHCCHHHHH
2.9422817900
106SulfoxidationKPPTYKLMTQAQLEE
CCCCHHHCCHHHHHH
1.9821406390
113UbiquitinationMTQAQLEEATRQAVE
CCHHHHHHHHHHHHH
65.0223503661
114UbiquitinationTQAQLEEATRQAVEA
CHHHHHHHHHHHHHH
9.9423503661
122UbiquitinationTRQAVEAAKVRLKMP
HHHHHHHHHHHHCCC
9.4322817900
123UbiquitinationRQAVEAAKVRLKMPP
HHHHHHHHHHHCCCC
34.6329967540
126UbiquitinationVEAAKVRLKMPPVLE
HHHHHHHHCCCCCHH
6.6222817900
127UbiquitinationEAAKVRLKMPPVLEE
HHHHHHHCCCCCHHC
38.5021906983
145UbiquitinationINDVLAEDKILEGTE
HHHHCCCCCCCCCCC
37.3722817900
146UbiquitinationNDVLAEDKILEGTET
HHHCCCCCCCCCCCC
40.4721906983
154UbiquitinationILEGTETTKYVFTDI
CCCCCCCEEEEEEEE
17.7223503661
155UbiquitinationLEGTETTKYVFTDIS
CCCCCCEEEEEEEEE
47.0023503661
156PhosphorylationEGTETTKYVFTDISY
CCCCCEEEEEEEEEC
9.9420068231
157UbiquitinationGTETTKYVFTDISYS
CCCCEEEEEEEEECC
4.4221890473
158UbiquitinationTETTKYVFTDISYSI
CCCEEEEEEEEECCC
4.6321890473
159PhosphorylationETTKYVFTDISYSIP
CCEEEEEEEEECCCC
23.5220068231
161UbiquitinationTKYVFTDISYSIPHR
EEEEEEEEECCCCCC
3.6522817900
162PhosphorylationKYVFTDISYSIPHRE
EEEEEEEECCCCCCC
18.6820068231
162UbiquitinationKYVFTDISYSIPHRE
EEEEEEEECCCCCCC
18.6822817900
163PhosphorylationYVFTDISYSIPHRER
EEEEEEECCCCCCCE
15.7920068231
164PhosphorylationVFTDISYSIPHRERF
EEEEEECCCCCCCEE
23.8920068231
169UbiquitinationSYSIPHRERFIVVRE
ECCCCCCCEEEEEEC
49.2422817900
170UbiquitinationYSIPHRERFIVVREP
CCCCCCCEEEEEECC
26.9222817900
178PhosphorylationFIVVREPSGTLRKAS
EEEEECCCCCCCCCC
39.3922210691
185PhosphorylationSGTLRKASWEERDRM
CCCCCCCCHHHHHCE
37.7522496350
196PhosphorylationRDRMIQVYFPKEGRK
HHCEEEEECCCCCCC
9.5921406692
198UbiquitinationRMIQVYFPKEGRKIL
CEEEEECCCCCCCCE
18.9921890473
199UbiquitinationMIQVYFPKEGRKILT
EEEEECCCCCCCCEE
64.0022817900
202UbiquitinationVYFPKEGRKILTPII
EECCCCCCCCEEEEE
24.7522817900
203UbiquitinationYFPKEGRKILTPIIF
ECCCCCCCCEEEEEE
53.5822817900
206PhosphorylationKEGRKILTPIIFKEE
CCCCCCEEEEEECHH
18.86-
210UbiquitinationKILTPIIFKEENLRT
CCEEEEEECHHHHHH
9.3722817900
211AcetylationILTPIIFKEENLRTM
CEEEEEECHHHHHHH
54.4319608861
211MalonylationILTPIIFKEENLRTM
CEEEEEECHHHHHHH
54.4326320211
211UbiquitinationILTPIIFKEENLRTM
CEEEEEECHHHHHHH
54.4322817900
244UbiquitinationPDSTEYIKVHHKTYE
CCCCCEEEEECCCHH
34.3129967540
244AcetylationPDSTEYIKVHHKTYE
CCCCCEEEEECCCHH
34.3125038526
248AcetylationEYIKVHHKTYEDIDK
CEEEEECCCHHHHHH
37.6125825284
248UbiquitinationEYIKVHHKTYEDIDK
CEEEEECCCHHHHHH
37.6129967540
248SuccinylationEYIKVHHKTYEDIDK
CEEEEECCCHHHHHH
37.6123954790
255SuccinylationKTYEDIDKRGKYDLL
CCHHHHHHCCCHHHH
64.4823954790
255AcetylationKTYEDIDKRGKYDLL
CCHHHHHHCCCHHHH
64.4825825284
255UbiquitinationKTYEDIDKRGKYDLL
CCHHHHHHCCCHHHH
64.4819608861
255MalonylationKTYEDIDKRGKYDLL
CCHHHHHHCCCHHHH
64.4826320211
258AcetylationEDIDKRGKYDLLRST
HHHHHCCCHHHHHCC
39.3625825284
258MalonylationEDIDKRGKYDLLRST
HHHHHCCCHHHHHCC
39.3626320211
264PhosphorylationGKYDLLRSTRYFGGM
CCHHHHHCCCCCCCE
19.7325921289
265PhosphorylationKYDLLRSTRYFGGMV
CHHHHHCCCCCCCEE
23.9725921289
274PhosphorylationYFGGMVWYFVNNKKI
CCCCEEEEEECCCEE
6.0425921289
280UbiquitinationWYFVNNKKIDGLLID
EEEECCCEECEEEHH
48.42-
2802-HydroxyisobutyrylationWYFVNNKKIDGLLID
EEEECCCEECEEEHH
48.42-
287UbiquitinationKIDGLLIDQIQRDLI
EECEEEHHHHHHHHH
39.2321890473
288UbiquitinationIDGLLIDQIQRDLID
ECEEEHHHHHHHHHH
27.0721890473
291UbiquitinationLLIDQIQRDLIDDAT
EEHHHHHHHHHHHHH
42.1922817900
292UbiquitinationLIDQIQRDLIDDATN
EHHHHHHHHHHHHHH
31.4422817900
311UbiquitinationYHVLHPDGQSAQGAK
HEEECCCCCCCCCCH
28.0021890473
315UbiquitinationHPDGQSAQGAKDQAA
CCCCCCCCCCHHHHH
58.5922817900
318UbiquitinationGQSAQGAKDQAAEGI
CCCCCCCHHHHHHHC
58.1429967540
328UbiquitinationAAEGINLIKVFAKTE
HHHHCCEEEEECCCH
2.8621890473
329UbiquitinationAEGINLIKVFAKTEA
HHHCCEEEEECCCHH
34.1721906983
329AcetylationAEGINLIKVFAKTEA
HHHCCEEEEECCCHH
34.1727452117
332UbiquitinationINLIKVFAKTEAQKG
CCEEEEECCCHHHCC
22.3522817900
333UbiquitinationNLIKVFAKTEAQKGA
CEEEEECCCHHHCCC
35.1222817900
333AcetylationNLIKVFAKTEAQKGA
CEEEEECCCHHHCCC
35.1225953088
349PhosphorylationIELTLQTYQEALSRH
EEEEHHHHHHHHHHH
7.4428348404
354PhosphorylationQTYQEALSRHSAAS-
HHHHHHHHHHHHCC-
34.6928348404
357PhosphorylationQEALSRHSAAS----
HHHHHHHHHCC----
25.1528348404
360PhosphorylationLSRHSAAS-------
HHHHHHCC-------
40.2328348404

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RT22_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RT22_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RT22_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RT25_HUMANMRPS25physical
22939629
RT35_HUMANMRPS35physical
22939629
RT26_HUMANMRPS26physical
22939629
SYQ_HUMANQARSphysical
22939629
T126A_HUMANTMEM126Aphysical
22939629
F192A_HUMANFAM192Aphysical
26344197
RT18B_HUMANMRPS18Bphysical
26344197
RT23_HUMANMRPS23physical
26344197
RT35_HUMANMRPS35physical
26344197
PTCD3_HUMANPTCD3physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
611719Combined oxidative phosphorylation deficiency 5 (COXPD5)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RT22_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-211; LYS-255 AND LYS-258,AND MASS SPECTROMETRY.

TOP